Home » Topics » Regulatory » Patents

Patents
RSS

Selective COX-2 inhibitors under study at Merck Frosst

Jan. 13, 1998

Novo Nordisk discloses peripheral muscarinic cholinergic agonists

Jan. 13, 1998

New muscarinic receptor modulators from Lilly

Jan. 13, 1998

New antiviral peptides from Boehringer Ingelheim

Jan. 12, 1998

More dopamine receptor ligands from Merck & Co.

Jan. 12, 1998

Neurogen describes D3 receptor-specific ligands

Jan. 12, 1998

Ketoacid ETA antagonists from Warner-Lambert

Jan. 12, 1998

Novel thalidomide prodrugs reported in patent literature

Jan. 12, 1998

Chiroscience synthesizes new MMP/TNF-inhibitory agents

Jan. 12, 1998

Cell adhesion inhibitors from Merck KGaA

Jan. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...